Back to the main directory
Event / Equity
- Espresso | Subsea 7 | Buy | New tie-back project (Sole), earnings release tomorrow morning by Kepler Cheuvreux
- Espresso | Viscofan | Reduce | EBITDA margin worse than expected by Kepler Cheuvreux
- Espresso | Nanobiotix | Buy | Q4 revenues by Kepler Cheuvreux
- Espresso | Rheinmetall | Hold | Very solid numbers by Kepler Cheuvreux
- Espresso | Teleperformance | Buy | FY 2016 results: sales light, EBIT in line, FCF better and prospects solid by Kepler Cheuvreux
- Espresso | Groupe Eurotunnel | Buy | FY 2016 results review by Kepler Cheuvreux
- Espresso | Zalando | Buy | 2016 as expected, somewhat cautious margin outlook for 2017 by Kepler Cheuvreux
- Espresso | Stada Arzneimittel | Buy | Q4 prelims slightly above street expectations, reassuring guidance by Kepler Cheuvreux
- Espresso | Liberbank | Reduce | Q4 2016 results confirm our thesis by Kepler Cheuvreux
- Espresso | Bonduelle | Under Review | H1 earnings and RPF deal financial metrics in line with expectations by Kepler Cheuvreux
- Espresso | Yoox Net-A-Porter | Buy | 2016 results and outlook in line with expectations by Kepler Cheuvreux
- Espresso | Luxottica | Buy | Unconvincing results and guidance despite better net profit by Kepler Cheuvreux
- Espresso | BioMérieux | Buy | 2016 results confirm our investment case by Kepler Cheuvreux
- Espresso | Genomic Vision | Buy | Focus on Life Science Research (LSR) by Kepler Cheuvreux
- Espresso | Evonik | Reduce | Solid Q4 results by Kepler Cheuvreux
- Espresso | Adecco | Buy | Trend remains up, share buyback by Kepler Cheuvreux
- Espresso | Roche | Hold | Major positive on APHINITY, but details at ASCO will be crucial by Kepler Cheuvreux
- Espresso | Deutsche Telekom | Buy | Slightly soft on EBITDA, adj. outlook broadly in line by Kepler Cheuvreux
- Espresso | Subsea 7 | Buy | Another strong beat by Kepler Cheuvreux
- Espresso | GAM Holding | Buy | FY miss on outflows, but cost progress and dividend maintained by Kepler Cheuvreux
- Espresso | Gemalto | Buy | Solid set of results, encouraging outlook and cheap valuation by Kepler Cheuvreux
- Espresso | Luxottica | Buy | 2017: another year of transition by Kepler Cheuvreux
- Espresso | Genfit | Buy | New acquisition speculation by Kepler Cheuvreux
- Espresso | ASM International | Buy | Strong finish to 2016, solid outlook for H1 2017 by Kepler Cheuvreux
- Espresso | Accor | Buy | Small acquisition in Brazil by Kepler Cheuvreux